Twist Bioscience

YTD

ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC.

CEO

Emily Marine Leproust

CEOEmily Marine Leproust

Employees

979

Employees979

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

979

Employees979

TWST Key Statistics

Market cap

10.05B

Market cap10.05B

Price-Earnings ratio

-56.31

Price-Earnings ratio-56.31

Dividend yield

—

Dividend yield—

Average volume

1.93M

Average volume1.93M

High today

$125.38

High today$125.38

Low today

$120.50

Low today$120.50

Open price

$124.12

Open price$124.12

Volume

1.61M

Volume1.61M

52 Week high

$125.66

52 Week high$125.66

52 Week low

$23.30

52 Week low$23.30

Stock Snapshot

With a market cap of 10.05B, Twist Bioscience(TWST) trades at $125.00. The stock has a price-to-earnings ratio of -56.31.

On 2026-08-13, Twist Bioscience(TWST) stock traded between a low of $120.50 and a high of $125.38. Shares are currently priced at $125.00, which is +3.7% above the low and -0.3% below the high.

The Twist Bioscience(TWST)'s current trading volume is 1.61M, compared to an average daily volume of 1.93M.

In the last year, Twist Bioscience(TWST) shares hit a 52-week high of $125.66 and a 52-week low of $23.30.

TWST News

24/7 Wall St. 2d

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It's Not Tech)

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech) By Gerelyn Terzo Publish...

Simply Wall St 3d

Twist Bioscience Is Up 26.3% After Equity Raise And Guidance Hike Has The Bull Case Changed?

In early August 2026, Twist Bioscience completed a US$300 million follow-on common stock offering at US$96 per share while raising its fiscal 2026 revenue guida...

Simply Wall St 5d

Twist Bioscience Could Be 25% Overvalued Following Higher Revenue Guidance

Advertisement Why Twist Bioscience Stock Is Back in Focus Twist Bioscience (TWST) moved back onto investors' radar after raising revenue guidance for fiscal 2...

Analyst ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell

More TWST News

Simply Wall St 7d

Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation Price Target To US$104 - simplywall.st

...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

IonQ

Block

Taiwan Semiconductor Manu…

Intellia Therapeutics

AMD

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.